Table 2.
Comparison of several types of patient-derived xenograft models
| PDX model | Advantage | Challenges |
|---|---|---|
| Subcutaneous model |
• Easy procedure • Minimized tissue damage of mice • Easy evaluation of tumor growth • Maintaining tumor architecture and clonality |
• Lack of proper tumor microenvironment • Lack of metastasis |
| Orthotopic model |
• Preservation of microenvironment of primary tumor • Spontaneous metastasis |
• Requirement of microsurgical skills • Imaging equipment required for longitudinal study |
| Subrenal model | • Increased blood supply for tumor growth |
• Requirement of microsurgical skills • Imaging equipment required for longitudinal study |
| Humanized model |
• Reconstitution of human immune cells • Evaluation of cancer immunotherapy |
• Requirement of long time for humanization and PDX generation • Limited reconstitution of human immune system |
| Stromal cell co-implantation model | • Supply of human stromal cells in tumor microenvironment | • Change of tumor characteristics by stomal cells |
| Circulating tumor cell (CTC)-derived model |
• Minimally invasive in patient • Easy to obtain samples • Applicable for otherwise unavailable tumor specimens • Preservation of intra-tumoral heterogeneity |
• Requirement of technique for the enrichment of CTCs • Variable concentration of CTCs in blood |